BRIEF-Icad’S Profound Ai For Digital Breast Tomosynthesis Version 3.0 Receives CE Mark Approval · 06/14 12:32
iCAD’s ProFound AI for Digital Breast Tomosynthesis Version 3.0 Receives CE Mark Approval
iCAD’s third generation artificial intelligence solution for 3D mammography offers considerable improvement in algorithm specificity performance and faster processing compared to previous generationsNASHUA, N.H., June 14, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc...
GlobeNewswire · 06/14 12:00
iCAD inks global distribution agreement with Sectra
iCAD (ICAD) has signed a worldwide distribution agreement with Sectra, an international medical imaging IT and cybersecurity company.Through the agreement, ProFound AI and ProFound AI Risk will be offered through the Sectra Amplifier Marketplace,
Seekingalpha · 06/08 12:18
iCAD Signs Global Distribution Agreement With Sectra; Terms Not Disclosed
 iCAD, Inc. (NASDAQ:ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it has signed a worldwide distribution agreement with Sectra, an
Benzinga · 06/08 12:09
iCAD to Participate in Upcoming Virtual Investor Conferences
iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, iCAD's Chairman and Chief Executive Officer, will be participating at the following three virtual...
GlobeNewswire · 05/17 20:05
iCAD Announces Educational Webinar Featuring Leading Global Experts Discussing New Multidisciplinary Approach for Treating Brain Tumors, May 25
Company sees positive momentum as research contributes to growing body of evidence supporting Xoft intraoperative radiotherapy (IORT) technology for brain cancerNASHUA, N.H., May 17, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical tech...
GlobeNewswire · 05/17 12:00
Global Computer Aided Detection System Market Size 2021 Analysis by Industry Share, Forthcoming Developments, End-User Demand, Size Estimation, Growth Factors, Challenges and Threats Faced by Key Vendors and Forecast Report till 2026
May 12, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Global “Computer Aided Detection System...
The Express Wire · 05/12 07:42
Brainsway Taps R. Scott Areglado as Finance Chief
MT Newswires · 05/05 10:50
Edgar Online - (EDG = 10Q, 10K) · 05/04 12:20
Medical Automation Market 2021 Development, Share, News and significant Growth with Regional Trends by Forecast 2028 | Says Kenneth Research
May 03, 2021 (AmericaNewsHour) -- Kenneth Research recently added a report on Medical Automation Market in its database of market research reports which...
AmericaNewsHour · 05/03 13:11
What are The Major Factors Expected to Limit The Growth Of The Radiotherapy Devices Market?
Heraldkeepers · 04/30 09:44
Analysts Offer Insights on Technology Companies: iCAD (ICAD) and BlackBerry (BB)
Companies in the Technology sector have received a lot of coverage today as analysts weigh in on iCAD (ICAD) and BlackBerry (BB). iCAD (ICAD) Oppenheimer
SmarterAnalyst · 04/29 04:25
iCAD (ICAD) Receives a Buy from BTIG
BTIG analyst Marie Thibault reiterated a Buy rating on iCAD (ICAD) yesterday and set a price target of $25.00. The company's shares closed last Wednesday
SmarterAnalyst · 04/29 01:35
(EDGAR Online via COMTEX) -- 0000749660 false ICAD INC 0000749660 2021-04-27 2021-04-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 04/28 22:21
Icad (ICAD) Reports Q1 Loss, Tops Revenue Estimates
Icad (ICAD) delivered earnings and revenue surprises of 36.36% and 6.36%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 04/28 22:15
BRIEF-Icad Inc- Repaid Obligations In Amount Of $7.4 Mln Under And Terminated Its Loan And Security Agreement Entered Into On March 30, 2020 · 04/28 22:08
BRIEF-Icad Q1 Loss Per Share $0.07 · 04/28 20:50
iCAD EPS beats by $0.04, beats on revenue
iCAD (ICAD): Q1 Non-GAAP EPS of -$0.07 beats by $0.04; GAAP EPS of -$0.07 beats by $0.05.Revenue of $8.64M (+31.9% Y/Y) beats by $0.66M.Press Release
Seekingalpha · 04/28 20:05
iCAD, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / April 28, 2021 / iCAD, Inc. (NASDAQ:ICAD) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on April 28, 2021 at 4:30 PM Eastern Time.
ACCESSWIRE · 04/28 18:45
Earnings Scheduled For April 28, 2021
  Companies Reporting Before The Bell • M/I Homes (NYSE:MHO) is likely to report quarterly earnings at $1.51 per share on revenue of $758.77 million.
Benzinga · 04/28 08:15
Webull provides a variety of real-time ICAD stock news. You can receive the latest news about ICAD US through multiple platforms. This information may help you make smarter investment decisions.
About ICAD
iCAD, Inc. is a provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The Company provides image analysis and clinical decision support solutions for mammography, Magnetic Resonance Imaging and Computed Tomography imaging. It operates in two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). The Detection segment consists of its advanced image analysis and workflow products, and the Therapy segment consists of its radiation therapy products. The Company sells its products through its direct sales organization, as well as through various original equipment manufacturer partners, distributors and resellers. It develops and markets computer-aided detection (CAD) solutions for digital and film-based mammography systems. Its Axxent SPX Controller includes an optimized skin treatment arm customized for compatibility in confined patient treatment rooms in physician office-based facilities.